These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25082541)

  • 21. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
    Imamura T; Hikita A; Inoue Y
    Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
    Tian H; Liu J; Chen J; Gatza ML; Blobe GC
    Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway.
    Cho HJ; Baek KE; Saika S; Jeong MJ; Yoo J
    Biochem Biophys Res Commun; 2007 Feb; 353(2):337-43. PubMed ID: 17187756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition.
    Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z
    Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
    Wang H; Fang R; Wang XF; Zhang F; Chen DY; Zhou B; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2013 Aug; 714(1-3):48-55. PubMed ID: 23769744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
    Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
    Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.
    Xu Q; Wang L; Li H; Han Q; Li J; Qu X; Huang S; Zhao RC
    Int J Oncol; 2012 Sep; 41(3):959-68. PubMed ID: 22766682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
    Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
    Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells.
    Yasui K; Shimamura M; Mitsutake N; Nagayama Y
    Thyroid; 2013 Aug; 23(8):989-96. PubMed ID: 23432420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
    Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
    Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
    Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
    J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
    Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
    Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.
    Oh TG; Wang SM; Acharya BR; Goode JM; Graham JD; Clarke CL; Yap AS; Muscat GEO
    EBioMedicine; 2016 Apr; 6():59-72. PubMed ID: 27211549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Snail regulated by PKC/GSK-3β pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells.
    Liu ZC; Chen XH; Song HX; Wang HS; Zhang G; Wang H; Chen DY; Fang R; Liu H; Cai SH; Du J
    Cell Tissue Res; 2014 Nov; 358(2):491-502. PubMed ID: 25124796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
    Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
    Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
    Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
    Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.